AC
ALGS icon

Armistice Capital’s Aligos Therapeutics ALGS Stock Holding History

Armistice Capital’s Portfolio ALGS Stock Details ALGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-315,095
Closed -$2.73M – 235
2024
Q3 		$2.73M Buy
315,095
+24,839
+9% +$309K 0.07% 149
2024
Q2 		$2.54M Buy
290,256
+14,520
+5% +$255K 0.07% 141
2024
Q1 		$6.76M Buy
275,736
+2,381
+0.9% +$47.4K 0.18% 112
2023
Q4 		$4.54M Buy
+273,355
New +$4.7M 0.12% 126

Other funds holding ALGS

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
TI
Trexquant Investment Stamford, Connecticut $13.8B AUM 31.98% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $699M AUM 600.17% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.37B AUM 63.08% 1-Year Est. Return